Inicial> Publicaciones > Artículos científicos y capítulos de libro

Torrens-Mas M, Hernández-López R, Pons DG, Roca P, Oliver J, Sastre-Serra J. Sirtuin 3 silencing impairs mitochondrial biogenesis and metabolism in colon cancer cells. Am J Physiol Cell Physiol. 2019 Jun 12. doi: 10.1152/ajpcell.00112.2019. [Epub ahead of print]+

Carrato A, Benavides M, Massutí B, Ferreiro-Monteagudo R, García Alfonso P, Falcó E, Reboredo M, Cano T, Gallego J, Viéitez JM, Layos L, Salud A, Polo E, Dotor E, Durán-Ogalla G, Rodriguez-Garrote M, Calvo A, Grande E, Aranda E. First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). BMC Cancer. 2019 Jun 3;19(1):533. doi: 10.1186/s12885-019-5753-7.

Pons DG, Vilanova-Llompart J, Gaya-Bover A, Alorda-Clara M, Oliver J, Roca P, Sastre-Serra J. The phytoestrogen genistein affects inflammatory-related genes expression depending on the ERα/ERβ ratio in breast cancer cells. Int J Food Sci Nutr. 2019 Apr 4:1-9. doi: 10.1080/09637486.2019.1597025. [Epub ahead of print]

Ortega V, Antón A, Garau I, Afonso N, Calvo L, Fernández Y, Martínez-García M, Blanco E, Zamora P, García M, Illarramendi JJ, Rodríguez Sánchez CA, Sampayo M, Aguirre E, Pérez-García JM, Cortés J, Llombart-Cussac A. Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study. Clin Breast Cancer. 2019 Apr;19(2):105-112. doi: 10.1016/j.clbc.2018.12.012. Epub 2018 Dec 20.

Sastre-Serra J, Ahmiane Y, Roca P, Oliver J, Pons DG. Xanthohumol, a hop-derived prenylflavonoid present in beer, impairs mitochondrial functionality of SW620 colon cancer cells. Int J Food Sci Nutr. 2019 Jun;70(4):396-404. doi: 10.1080/09637486.2018.1540558. Epub 2018 Nov 20.

Cordani M, Butera G, Dando I, Torrens-Mas M, Butturini E, Pacchiana R, Oppici E, Cavallini C, Gasperini S, Tamassia N, Nadal-Serrano M, Coan M, Rossi D, Gaidano G, Caraglia M, Mariotto S, Spizzo R, Roca P, Oliver J, Scupoli MT, Donadelli M. Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O(2-)· production in cancer cells. Br J Cancer. 2018 Oct;119(8):994-1008.

Hernández-López R, Torrens-Mas M, Pons DG, Company MM, Falcó E, Fernández T, Ibarra de la Rosa JM, Sastre-Serra J, Oliver J, Roca P. Non-tumor adjacent tissue of advanced stage from CRC shows activated antioxidant response. Free Radic Biol Med. 2018 Oct;126:249-258.

Redondo A, Ramos Vázquez M, Manso L, Gil Gil MJ, Garau Llinas I, García-Garre E, Rodríguez CA, Chacón JI, López-Vivanco G. Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational "LORENA" study. Onco Targets Ther. 2018 Sep 17;11:5845-5852. doi: 10.2147/OTT.S170303. eCollection 2018.

Aranda E, García-Alfonso P, Benavides M, Sánchez Ruiz A, Guillén-Ponce C, Safont MJ, Alcaide J, Gómez A, López R, Manzano JL, Méndez Ureña M, Sastre J, Rivera F, Grávalos C, García T, Martín-Valadés JI, Falcó E, Navalón M, González Flores E, Ma García Tapiador A, Ma López Muñoz A, Barrajón E, Reboredo M, García Teijido P, Viudez A, Cárdenas N, Díaz-Rubio E; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study. Eur J Cancer. 2018 Sep;101:263-272. doi: 10.1016/j.ejca.2018.06.024.

García-Alfonso P, Benavides M, Falcó E, Muñoz A, Gómez A, Sastre J, Rivera F, Montagut C, Salgado M, López-Ladrón A, López R, Ruiz de Mena I, Durán G, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD). Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial). Oncologist. 2018 Aug 17. pii: theoncologist.2018-0316. doi: 10.1634/theoncologist.2018-0316.

Alonso V, Escudero P, Fernández-Martos C, Salud A, Méndez M, Gallego J, Rodriguez JR, Martín-Richard M, Fernández-Plana J, Manzano H, Méndez JC, Zanui M, Falcó E, Gil-Raga M, Rojo F, Cuatrecasas M, Feliu J, García-Albéniz X, Maurel J. Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients. Neoplasia. 2018 Jul;20(7):678-686. doi: 10.1016/j.neo.2018.05.004. Epub 2018 May 26.

Torrens-Mas M, Hernández-López R, Oliver J, Roca P, Sastre-Serra J. Sirtuin 3 silencing improves oxaliplatin efficacy through acetylation of MnSOD in colon cancer. J Cell Physiol. 2018 Aug;233(8):6067-6076. doi: 10.1002/jcp.26443. Epub 2018 Mar 6.

Colombo N, Huang G, Scambia G, Chalas E, Pignata S, Fiorica J, Van Le L, Ghamande S, González-Santiago S, Bover I, Graña Suárez B, Green A, Huot-Marchand P, Bourhis Y, Karve S, Blakeley C. Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer. J Clin Oncol. 2018 May 1;36(13):1300-1307. doi: 10.1200/JCO.2017.76.2781. Epub 2018 Mar 20.

Esteban I, Vilaró M, Adrover E, Angulo A, Carrasco E, Gadea N, Sánchez A, Ocaña T, Llort G, Jover R, Cubiella J, Servitja S, Herráiz M, Cid L, Martínez S, Oruezábal-Moreno MJ, Garau I, Khorrami S, Herreros-de-Tejada A, Morales R, Cano JM, Serrano R, López-Ceballos MH, González-Santiago S, Juan-Fita MJ, Alonso-Cerezo C, Casas A, Graña B, Teulé A, Alba E, Antón A, Guillén-Ponce C, Sánchez-Heras AB, Alés-Martínez JE, Brunet J, Balaguer F, Balmaña J. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain. Psychooncology. 2018 Jun;27(6):1530-1537. doi: 10.1002/pon.4686. Epub 2018 Mar 26.

Nuciforo P, Pascual T, Cortés J, Llombart-Cussac A, Fasani R, Paré L, Oliveira M, Galvan P, Martínez N, Bermejo B, Vidal M, Pernas S, López R, Muñoz M, Garau I, Manso L, Alarcón J, Martínez E, Rodrik-Outmezguine V, Brase JC, Villagrasa P, Prat A, Holgado E. A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade. Ann Oncol. 2018 Jan 1;29(1):170-177. doi: 10.1093/annonc/mdx647.

González-Cao M, Arance A, Piulats JM, Marquez-Rodas I, Manzano JL, Berrocal A, Crespo G, Rodriguez D, Perez-Ruiz E, Berciano M, Soria A, Castano AG, Espinosa E, Montagut C, Alonso L, Puertolas T, Aguado C, Royo MA, Blanco R, Rodríguez JF, Muñoz E, Mut P, Barron F, Martin-Algarra S; Spanish Melanoma Group. Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program. Clin Transl Oncol. 2017 Jun;19(6):761-768. doi: 10.1007/s12094-016-1602-1. Epub 2017 Jan 4.

Mesía R, Garcia-Saenz JA, Lozano A, Pastor M, Grau JJ, Martínez-Trufero J, Lambeaz J, Martínez-Galán J, Mel JR, González B, Vázquez S, Mañós M, Taberna M, Cirauqui B, Del Barco E, Casado E, Rubió-Casadevall J, Rodríguez-Jaráiz A, Cruz JJ; Spanish Head And Neck Cancer Cooperative Group (Study TTCC-2007/02). Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):473-480. doi: 10.1016/j.ijrobp.2016.11.016. Epub 2016 Nov 17.

Torrens-Mas M, Roca P, Sastre-Serra J. Importancia de la sirtuina 3 en el estrés oxidativo y el càncer. Medicina Balear 32: 47-52 (2017).

Calvete O, Herraiz M, Reyes J, Patiño A, Benitez J. A cumulative effect involving malfunction of the PTH1R and ATP4A genes explains a familial gastric neuroendocrine tumor with hypothyroidism and arthritis. Gastric Cancer. 2017 May 4. doi: 10.1007/s10120-017-0723-8. [Epub ahead of print]

Torrens-Mas M, González-Hedström D, Abrisqueta M, Roca P, Oliver J, Sastre-Serra J. PGC-1α in Melanoma: A Key Factor for Antioxidant Response and Mitochondrial Function. J Cell Biochem. 2017 Apr 27. doi: 10.1002/jcb.26094. [Epub ahead of print]

Torrens-Mas M, Oliver J, Roca P, Sastre-Serra J. SIRT3: Oncogene and Tumor Suppressor in Cancer. Cancers (Basel). 2017 Jul 12;9(7). pii: E90. doi: 10.3390/cancers9070090. Review.

Grasselli J, Elez E, Caratù G, Matito J, Santos C, Macarulla T, Vidal J, Garcia M, Viéitez JM, Paéz D, Falcó E, Lopez Lopez C, Aranda E, Jones F, Sikri V, Nuciforo P, Fasani R, Tabernero J, Montagut C, Azuara D, Dienstmann R, Salazar R, Vivancos A. Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer. Ann Oncol. 2017 Jun 1;28(6):1294-1301.

Irigoyen A, Gallego J, Guillén Ponce C, Vera R, Iranzo V, Ales I, Arévalo S, Pisa A, Martín M, Salud A, Falcó E, Sáenz A, Manzano Mozo JL, Pulido G, Martínez Galán J, Pazo-Cid R, Rivera F, García García T, Serra O, Fernández Parra EM, Hurtado A, Gómez Reina MJ, López Gomez LJ, Martínez Ortega E, Benavides M, Aranda E; Spanish Cooperative Group of Treatment of Digestive Tumors (TTD). Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group. Eur J Cancer. 2017 Feb 17;75:73-82.

Blanquer-Rosselló MD, Hernández-López R, Roca P, Oliver J, Valle A. Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells. Biochim Biophys Acta. 2017 Feb;1861(2):431-440.

Torrens-Mas M, Pons DG, Sastre-Serra J, Oliver J, Roca P. SIRT3 Silencing Sensitizes Breast Cancer Cells to Cytotoxic Treatments through an Increment in ROS Production. J Cell Biochem. 2017 Feb;118(2):397-406.

Brandi J, Cecconi D, Cordani M, Torrens-Mas M, Pacchiana R, Pozza ED, Butera G, Manfredi M, Marengo E, Oliver J, Roca P, Dando I, Donadelli M. The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition. Free Radic Biol Med. 2016 Dec; 101: 305-16.

Isla D, Felip E, Viñolas N, Provencio M, Majem M, Artal A, Bover I, Lianes P, DE Las Peñas R, Catot S, DE Castro J, Blasco A, Terrasa J, Gonzalez-Larriba JL, Juan O, Dómine M, Bernabe R, Garrido P. Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07. Anticancer Res. 2016 Dec;36(12):6647-6653.

Cordani M, Oppici E, Dando I, Butturini E, Dalla Pozza E, Nadal-Serrano M, Oliver J, Roca P, Mariotto S, Cellini B, Blandino G, Palmieri M, Di Agostino S, Donadelli M. Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition. Mol Oncol. 2016 Aug; 10(7): 1008-29.

Kurzeder C, Bover I, Marmé F, Rau J, Pautier P, Colombo N, Lorusso D, Ottevanger P, Bjurberg M, Marth C, Barretina-Ginesta P, Vergote I, Floquet A, Del Campo JM, Mahner S, Bastière-Truchot L, Martin N, Oestergaard MZ, Kiermaier A, Schade-Brittinger C, Polleis S, du Bois A, Gonzalez-Martin A. Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE). J Clin Oncol. 2016 Jul 20;34(21):2516-25.

Barni S, Freier B, Garau I, Mouysset JL, Sediva M, Zamagni C, Berdeaux G, de Almeida Agudo C. Burden of advanced breast cancer for patients and caregivers in Europe: Comparison of two treatment forms of vinorelbine, oral and intravenous. Curr Med Res Opin. 2016 Jul 8:1-24.

Blanquer-Rosselló MM, Oliver J, Sastre-Serra J, Valle A, Roca P. Leptin regulates energy metabolism in MCF-7 breast cancer cells. Int J Biochem Cell Biol. 2016 Mar;72:18-26.

Pons DG, Nadal-Serrano M, Torrens-Mas M, Oliver J, Roca P. The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio. J Cell Biochem. 2016 Jan;117(1):218-29.

Pons DG, Nadal-Serrano M, Torrens-Mas M, Oliver J, Roca P. The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio. J Cell Biochem. 2015 Sep;66:85-94.

Pons DG, Torrens-Mas M, Nadal-Serrano M, Sastre-Serra J, Roca P, Oliver J. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents. Int J Biochem Cell Biol. 2015 Sep;66:85-94.

Pons DG, Nadal-Serrano M, Torrens-Mas M, Valle A, Oliver J, Roca P. UCP2 inhibition sensitizes breast Cancer cells to therapeutic agents by increasing oxidative stress. Free Radic Biol Med. 2015 Sep;86:67-77.

Blanquer-Rosselló MD, Santandreu FM, Oliver J, Roca P, Valle A. Leptin Modulates Mitochondrial Function, Dynamics and Biogenesis in MCF-7 Cells. J Cell Biochem. 2015 Sep;116(9):2039-48.

Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ; ICON7 trial investigators. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncol. 2015 Aug;16(8):928-36.

Nadal-Serrano M, Sastre-Serra J, Torrens-Mas M, Abrisqueta M, Castejón M, Oliver J, Roca P. La estimulación de PGC-1α a través de MC1R en el melanoma aumenta la biogénesis mitocondrial y la respuesta antioxidante. Medicina Balear 2015 May-Ago, 30(2): 37-42.

Karachaliou N1, Mayo-de las Casas C2, Queralt C3, de Aguirre I3, Melloni B4, Cardenal F5, Garcia-Gomez R6, Massuti B7, Sánchez JM8, Porta R9, Ponce-Aix S10, Moran T3, Carcereny E3, Felip E11, Bover I12, Insa A13, Reguart N14, Isla D15, Vergnenegre A4, de Marinis F16, Gervais R17, Corre R18, Paz-Ares L19, Morales-Espinosa D1, Viteri S1, Drozdowskyj A20, Jordana-Ariza N2, Ramirez-Serrano JL3, Molina-Vila MA2, Rosell R21; Spanish Lung Cancer Group. Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial. JAMA Oncol. 2015 May;1(2):149-57.

Nadal-Serrano M, Sastre-Serra J, Valle A, Roca P, Oliver J. Chronic-leptin attenuates cisplatin cytotoxicity in MCF-7 breast cancer cell line. Cell Physiol Biochem. 2015 May; 36(1):221-32.

Colom B, Oliver J, Garcia-Palmer FJ. Sexual Dimorphism in the Alterations of Cardiac Muscle Mitochondrial Bioenergetics Associated to the Ageing Process. J Gerontol A Biol Sci Med Sci. 2014 Mar 28. [Epub ahead of print]

Gonzalez-Martín A, Bover I, Del Campo JM, Redondo A, Vidal L. SEOM guideline in ovarian cancer 2014. Clin Transl Oncol. 2014 Dec;16(12):1067-71

Moran T, Wei J, Cobo M, Qian X, Domine M, Zou Z, Bover I, Wang L, Provencio M, Yu L, Chaib I, You C, Massuti B, Song Y, Vergnenegre A, Lu H, Lopez-Vivanco G, Hu W, Robinet G, Yan J, Insa A, Xu X, Majem M, Chen X, de Las Peñas R, Karachaliou N, Sala MA, Wu Q, Isla D, Zhou Y, Baize N, Zhang F, Garde J, Germonpre P, Rauh S, ALHusaini H, Sanchez-Ronco M, Drozdowskyj A, Sanchez JJ, Camps C, Liu B, Rosell R; Spanish Lung Cancer Group; French Lung Cancer Group; Comprehensive Cancer Centre of Drum Tower Hospital in Nanjing. Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies. Ann Oncol. 2014 Nov;25(11):2147-55.

Roca P, Sastre-Serra J, Nadal-Serrano M, Pons DG, Blanquer-Rossello MD, Oliver J. Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio. Curr Pharm Des. 2014;20(35):5594-618.

Pons DG, Nadal-Serrano M, Blanquer-Rossello MM, Sastre-Serra J, Oliver J, Roca P. Genistein Modulates Proliferation and Mitochondrial Functionality in Breast Cancer Cells Depending on ERalpha/ERbeta Ratio. J Cell Biochem. 2014 May;115(5):949-58.

Blanquer-Rosselló MM, Oliver J, Valle A, Roca P. Effect of xanthohumol and 8-prenylnaringenin on MCF-7 breast cancer cells oxidative stress and itochondrial complexes expression. J Cell Biochem. 2013 Dec;114(12):2785-94.

Lecumberri R, López Vivanco G, Font A, González Billalabeitia E, Gúrpide A, Gómez Codina J, Isla D, Galán A, Bover I, Domine M, Vicente V, Rosell R, Rocha E. Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study. Thromb Res. 2013;132(6):666-70.

Nadal-Serrano M, Pons DG, Sastre-Serra J, Blanquer-Rosselló MD, Roca P, Oliver J. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio. Effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes. Int J Biochem Cell Biol. 2013 Sep;45(9):2045-51

González Martín A, Redondo A, Jurado M, De Juan A, Romero I, Bover I, Del Campo JM, Cervantes A, García Y, López-Guerrero JA, Mendiola C, Palacios J, Rubio MJ, Poveda Velasco A. GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012. Clin Transl Oncol. 2013 Jul;15(7):509-25.

Sastre-Serra J, Nadal-Serrano M, Gabriel Pons D, Roca P, Oliver J. The over-expression of ERbeta modifies estradiol effects on mitochondrial dynamics in breast cancer cell line. Int J Biochem Cell Biol. 2013 Apr 22;45(7):1509-1515. (DOI: 10.1016/j.biocel.2013.04.007)

Sastre-Serra J, Nadal-Serrano M, Gabriel Pons D, Valle A, Garau I, García-Bonafé M, Oliver J, Roca P. The oxidative stress in breast tumors of postmenopausal women is ERα/ERβ ratio dependent. Free Radic Biol Med. 2013 Mar 14; 61C:11-17. (DOI: 10.1016/j.freeradbiomed.2013.03.005). [Epub ahead of print]

Pons DG, Sastre-Serra J, Nadal-Serrano M, Oliver A, García-Bonafé M, Bover I, Roca P, Oliver J. Initial activation status of the antioxidant response determines sensitivity to carboplatin/paclitaxel treatment of ovarian cancer. Anticancer Res. 2012 Nov;32(11):4723-8.

Ramalingam SS, Blackhall F, Krzakowski M, Barrios CH, Park K, Bover I, Seog Heo D, Rosell R, Talbot DC, Frank R, Letrent SP, Ruiz-Garcia A, Taylor I, Liang JQ, Campbell AK, O'Connell J, Boyer M. Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2012 Sep 20;30(27):3337-44.

Sastre-Serra J, Nadal-Serrano M., Pons D.G., Roca P., Oliver J. Mitochondrial dynamics is affected by 17β-estradiol in the MCF-7 breast cancer cell line. Effects on fusion and fission related genes. Int J Biochem Cell Biol. 2012 44(11): 1901-5.

Nadal-Serrano M, Sastre-Serra J, Pons DG, Miró AM, Oliver J, Roca P. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol. J Cell Biochem. 2012 May 21, 113(10):3178-85.

Sastre-Serra J, Nadal-Serrano M, Pons DG, Valle A, Oliver J, Roca P. The effects of 17β-estradiol on mitochondrial biogenesis and function in breast cancer cell lines are dependent on the ERα/ERβratio. Cell Physiol Biochem, 2012; 29(1-2):261-268.

Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia-Gomez R, Pallares C, Sanchez JM, Porta R, Cobo M, Garrido P, Longo F, Moran T, Insa A, De Marinis F, Corre R, Bover I, Illiano A, Dansin E, de Castro J, Milella M, Reguart N, Altavilla G, Jimenez U, Provencio M, Moreno MA, Terrasa J, Muñoz-Langa J, Valdivia J, Isla D, Domine M, Molinier O, Mazieres J, Baize N, Garcia-Campelo R, Robinet G, Rodriguez-Abreu D, Lopez-Vivanco G, Gebbia V, Ferrera-Delgado L, Bombaron P, Bernabe R, Bearz A, Artal A, Cortesi E, Rolfo C, Sanchez-Ronco M, Drozdowskyj A, Queralt C, de Aguirre I, Ramirez JL, Sanchez JJ, Molina MA, Taron M, Paz-Ares L; on behalf of the Spanish Lung Cancer Group in collaboration with the Groupe Français de Pneumo-Cancérologie and the Associazione Italiana Oncologia Toracica. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 2012 Mar;13(3):239-46.

Di Gaudio F, Calò V, La Paglia L, Bruno L, Di Piazza F, Margarese N, Guadagna FP, Guarneri G, Cicero G, Ricciardi GR, Rolfo Cervetto C, Cucinella G, Pantuso G, Bazan V, Russo A. What Are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? Current Women’s Health Reviews, 2012, 8(1):65-71.

Di Gaudio F, La Paglia L, Calò V, Bruno L, Di Piazza F, Margarese N, Gulotta E, Cicero G, Bronte G, Rizzo S, Franchina T, Rolfo Cervetto C, Cucinella G, Bazan V, Russo A. How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? Current Women’s Health Reviews, 2012, (1):38-43.

Bover I, Rolfo C, Jantus-Lewintre E, Sirera R, Camps C, Chaib I, Ramirez-Serrano JL, Benlloch S, Molina-Vila MA, Simonetti S, Costa C, Gimenez-Capitan A, Mendez P, Taron M, Rosell R. Fifth Educational Symposium of the Spanish Lung Cancer Group: Report on the Molecular Biology Workshop. Lung Cancer. 2011; 74(3):535-43.

Iván Henriquez López, Benjamin Guix Melchor, Oscar Abuchaibe, Christian Rolfo Cervetto, Meritxel Arenas Prats. RECIDIVA BIOQUIMICA Y LOCAL EN EL CÁNCER DE PRÓSTATA DESPUÉS DE RADIOTERAPIA. ¿QUÉ HACER Y CÓMO HACERLO? En: CONTROVERSIAS EN EL CÁNCER DE PRÓSTATA 2. Editores: Mack Roach III e Iván Henriquez López. Editorial: Visto Bueno Equipo Creativo, S.L. Noviembre 2011.

Santandreu FM, Valle A, Oliver J, Roca P. Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells. Cell Physiol Biochem. 2011;28(2):219-28.

Roca P, Oliver J, Sastre-Serra J, Nadal-Serrano M. The Importance of ERα/ERβ Ratio in Breast Cancer: Mitochondrial Function and Oxidative Stress. En: Breast Cancer - Carcinogenesis, Cell Growth and Signalling Pathways. Editado por Mehmet Gunduz and Esra Gunduz. ISBN 978-953-307-714-7 Publisher: InTech, November 2011

Di Fede G, Bronte G, Rizzo S, Rolfo Cervetto C, Cocorullo G, Gulotta G, Bazan V, Russo A. Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors. Expert Opin Biol Ther. 2011 Jun 12. 11 (11): 1433-1445.

Valle A, Sastre-Serra J, Pol C, Miró AM, Oliver J, Roca P. Proteomic analysis of MCF-7 breast cancer cell line exposed to leptin. Anal Cell Pathol (Amst). 2011 jul; 34(3):147-157.

Santandreu FM, Oliver J, Roca P. Chapter 8. Metabolic differences in different regions of glioma samples. En: Tumors of the Central Nervous System, Volume 2. Gliomas: Glioblastoma (Part 2). Hayat, M.A. (Ed.) Springer. 2011.

Miró AM, Sastre-Serra J, Pons DG, Valle A, Roca P, Oliver J. 17β-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio. J Steroid Biochem Mol Biol. 2011 Feb; 123(3-5): 133–139.

Valle A, Sastre-Serra J, Oliver J, Roca P. Chronic leptin treatment sensitizes mcf-7 breast cancer cells to estrogen. Cell Physiol Biochem. 2011;28(5):823-32.

Morales R, Cuadrado A, Noguera JF, Dolz C, Vilella A, Riera J, González de Cabo M, Arriví A, Falcó E, García Bonafe M, Company M, Vicens JC, Socías A. Multidisciplinary approach and multimodal therapy in resected pancreatic cancer. Observational study. Rev Esp Enferm Dig. 2011 Jan;103(1):5-12.

Santandreu FM, Oliver J, Roca P. Improvement of mitochondrial energy and oxidative balance during intestinal differentiation. Mitochondrion. 2011 Jan; 11(1):89-96.

Quaderns de Càncer de les Illes Balears 2. El càncer a Mallorca 1997-2000 incidència i mortalitat. M Ramos, P. Franch, I. Garau ISSN 1695-2899 Conselleria de Salut i Consum Palma març 2010

Marcos-Gragera R, Pollán M, Chirlaque MD, Gumà J, Sanchez MJ, Garau I; Non-Hodgkin's Lymphoma Working Group. Attenuation of the epidemic increase in non-Hodgkin's lymphomas in Spain. Ann Oncol. 2010 May;21 Suppl 3:iii90-96.

Navarro C, Martos C, Ardanaz E, Galceran J, Izarzugaza I, Peris-Bonet R, Martínez C; Spanish Cancer Registries Working Group. Population-based cancer registries in Spain and their role in cancer control. Ann Oncol. 2010 May;21 Suppl 3:iii3-13. Review.

Peris-Bonet R, Salmerón D, Martínez-Beneito MA, Galceran J, Marcos-Gragera R, Felipe S, González V, Sánchez de Toledo Codina J; Spanish Childhood Cancer Epidemiology Working Group. Childhood cancer incidence and survival in Spain. Ann Oncol. 2010 May;21 Suppl 3:iii103-110.

Pita S, Pertegaz S, López B, Gómez P, Seoane T, Arnal F, Macià M, Sánchez MA, Espí, A, Valladares M, Pazos A, Reboredo M, González L, Ramos M, Segura JM, Monreal I, González L, Martín M, Murta C, Pueyo O, Maia M, Cabeza E, Casamitjana M, Pinilla M, costa A, Ruiz A, Burón A, García C, Bennasar ML, Lafita S, Novella M, Manzano H, Vadell C, Falcó E, Esteva M. Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol. BMC Cancer 2010; 10: 528.

Sastre-Serra J, Valle A, Company M, Garau I, Oliver J, Roca P. Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer. Free Radic Biol Med. 2010 Feb 15; 48(4):506-12.

Valle A, Oliver J, Roca P. Role of Uncoupling Proteins in Cancer. Cancers 2010, 2(2): 567-591

Sastre-Serra J, Valle A, Company M, Garau I, Oliver J, Roca P. Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer. Free Radic Biol Med. 2010 Feb 15; 48(4):506-12.

Santandreu FM, Valle A, Fernández de Mattos S, Roca P, Oliver J. Hydrogen Peroxide Regulates the Mitochondrial Content of Uncoupling Protein 5 in Colon Cancer Cells. Cell Physiol Biochem, 2009, 24: 379-390.

Santandreu FM, Oliver J, Roca P. Resveratrol enhances 5-fluorouracil and cisplatin cytotoxicity in colon cancer cells. Free Radicals Health and Lifestyle, 2009, 121-126. (Index pdf)

Santandreu FM, Oliver J, Roca P. Implications of oxidative stress and mitochondrial damage in the response of colon cancer cells to cisplatin. Free Radicals Health and Lifestyle, 2009, 115-120. (Index pdf)

Company-Campins MM, Morales R, Dolz C, Garcia-Bonafe M, Vilella A, Huguet P. Primary monophasic synovial sarcoma of the duodenum confirmed by cytogenetic analysis with demostration of t(X;18): a case report. J Gastrointestin Liver Dis 2009;18:89-93.

Garcia-Bonafe MM, Company Campins MM, Huguet Redecilla P. Malignant Nodular Hidradenoma on the Scalp: Report of a Case with Fine Needle Aspiration Cytology Features and Histologic Correlation. Acta Cytologica 2009;53: 576-583.

Ciuleanu T, Brodow icz T, Zielinski C, Kim JH, Krzakowski M, Laack E, Wu YL, Bover I, Beg bie S, Tzekova V, Cucevic B, Pereira JR, Yang SH, Madhavan J, Sugarman KP, Peterson P, John WJ, Krejcy K, Belani CP. Maintenance permetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer, a randomised, double-blind, phase 3 study. Lancet. 2009 Oct 24;374(9699):1432-40.

Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, Majem M, Lopez-Vivanco G, Isla D, Provencio M, Insa A, Massuti B, Gonzalez-Larr iba JL, Paz-Ares L, Bover I, Garcia-Campelo R, Moreno MA, Catot S, Rolfo C, Reguart N, Palmero R, Sánchez JM, Bastus R, Mayo C, Bertran-Alamillo J, Molina MA, Sanchez JJ, Taron M. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med. 2009 Sep 3;361(10):958-67.

Santandreu FM, Brell M, Gene AH, Guevara R, Oliver J, Couce ME, Roca P. Differences in Mitochondrial Function and Antioxidant Systems between Regions of Human Glioma. Cell Physiol Biochem. 2008;22(5-6):757-68.

Díaz N, Menjón S, Rolfo C, García-Alonso P, Carulla J, Magro A, Miramón J, Rodríguez CA, de Castellar R, Gasquet JA. Patients' perception of cancer-related fatigue: results of a survey to assess the impact on their everyday life. Clin Transl Oncol. 2008 Nov;10(11):753-7.

Blanco R, Solçé J, Montesinos J, Mesia C, Algara M, Terrasa J, Gay M, Domenech M, Bastús R, Bover I, Nogué M, Vadell C. On behalf of ACROSS. Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: Final results of a phase II study. Lung Cancer 2008; 62:62-71.

Paz-Ares L, Ross H, O'Brien M, Riviere A, Gatzemeier U, Von Pawel J, Kaukel E, Freitag L, Digel W, Bischoff H, García-Campelo R, Iannotti N, Reiterer P, Bover I, Prendiville J, Eisenfeld AJ, Oldham FB, Bandstra B, Singer JW, Bonomi P. Phase III trial comparing paclitaxel poliglumex vas docetaxel in the second-line tratment of non-small-cell lung cancer. Br J Cancer. 2008 May 20;98(10):1608-13.

Luna F, Roca P, Oliver J, Antenucci CD. Maximal thermogenic capacity and non shivering thermogenesis in the South American subterranean rodent Ctenomys talarum. J Comp Physiol B, 2012, 182(7): 971-83.

Valle A, Catalán V, Rodríguez A, Rotellar F, Valentí V, Silva C, Salvador J, Fühbeck G, Gómez-Ambrosi J, Roca P, Oliver J. Identification of liver proteins altered by Type 2 Diabetes Mellitus in obese subjects. Liver Int. 2012; 32(6): 951-61.

Guevara R, Gianotti M, Oliver J, Roca P. Age and sex-related changes in rat brain mitochondrial oxidative status. Exp Gerontol. 2011 46(11):923-928.

Bosch-Presegué L, Raurell-Vila H, Marazuela-Duque A, Kane-Goldsmith N, Valle A, Oliver J, Serrano L, Vaquero A. Stabilization of Suv39H1 by SirT1 Is Part of Oxidative Stress Response and Ensures Genome Protection. Mol Cell. 2011 Apr 22; 42(2):210-23.

Guevara R, Gianotti M, Roca P, Oliver J. Age and Sex-Related Changes in Rat Brain Mitochondrial Function. Cell Physiol Biochem 2011;27:201-206 (DOI: 10.1159/000327945)

Valle A, Sastre-Serra J, Roca P, Oliver J. Modulation of white adipose tissue proteome by aging and calorie restriction. Aging Cell. 2010 Oct;9(5):882-894.

Essop MF, Anna Chan WY, Valle A, García-Palmer FJ, Du Toit EF. Impaired contractile function and mitochondrial respiratory capacity in response to oxygen deprivation in a rat model of pre-diabetes. Acta Physiol (Oxf). 2009 Dec; 197 (4): 289-96. Epub 2009 Jul 23.

Aguilar JL, March Y, Segarra M, Moyá MM, Peláez R, Fernández S, Roca P, García-Palmer FJ, Grupo CODO con CODO Bio-Balear. Prevalencia de dolor en un hospital con unidad de dolor agudo y unidad de dolor crónico: el paso siguiente... analgesia traslacional. Rev Soc Esp Dolor, 2009 May, 16(4): 209-214.

Guevara R, Santandreu FM, Valle A, Gianotti M, Oliver J, Roca P. Sex-dependent differences in old rat brain mitochondrial function and oxidative stress. Free Rad Biol Med; 2009 Jan 15;46(2):169-175. Epub 2008 Oct 17.

Valle A, Santandreu FM, García-Palmer FJ, Roca P, Oliver J. The serum levels of 17beta-estradiol, progesterone and triiodothyronine correlate with brown adipose tissue thermogenic parameters during aging. Cell Physiol Biochem. 2008;22(1-4):337-46.

Valle A, Guevara R, García-Palmer FJ, Roca P, Oliver J. Caloric restriction retards the age-related decline in mitochondrial function of brown adipose tissue. Rejuvenation Res. 2008 Jun;11(3):597-604.

Valle A, Silvestri E, Moreno M, Chambery A, Oliver J, Roca P, Goglia F. Combined effect of gender and caloric restriction on liver proteomic expression profile. J Proteome Res. 2008 Jul;7(7):2872-81.

Guevara R, Valle A, Gianotti M, Roca P, Oliver J. Gender-dependent Differences in Serum Profiles of Insulin and Leptin in Caloric Restricted Rats. Horm Metab Res. 2008 Jan; 40(1):38-43.

Valle A, Hoggard N, Adams AC, Roca P, Speakman JR. Chronic Central Administration of Apelin-13 Over 10 Days Increases Food Intake, Body Weight, Locomotor Activity and Body Temperature in C57BL/6 Mice. J Neuroendocrinol. 2008 Jan;20(1):79-84.